Friday, May 9, 2008

Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Gr

Posted by kucinx at 11:55 AM

No comments:

Loading....

Post a Comment

Subscribe to: Post Comments (Atom)